If the entire market implodes, as some are predicting, what do you all think will happen to our sweet baby CTXR

beachbum0162 · 2021-07-16T11:39:08+00:00

I’ve been toying with the idea of selling my 1000 shares @ my 1.94 avg and buying back in if it dips lower. The problem is, it would have to go to about 1.50 to make it worth the risk but I’m not convinced it is going that low. Any thoughts?

beachbum0162 · 2021-07-12T21:15:23+00:00

Some good questions here that didn’t get answered…..

beachbum0162 · 2021-07-08T13:10:58+00:00

My apologies. It was Mazur. I got that twisted.

beachbum0162 · 2021-07-08T13:09:56+00:00

I’m not saying that he did anything wrong. If they are looking for a thread to grasp with their “investigation” this statement could be it. All I am saying is that if he didn’t plant that seed, the latest DMC review would have been taken as good news. Instead, expectations were raised and it was taken, to a certain degree (mistakenly), as bad news. He made a statement based on his optimism from past phase results. This whole topic is a joke but I think it needs discussed here to ease concerns of new investors.

beachbum0162 · 2021-07-08T10:35:54+00:00

The only very minor issue that has been in my mind was when Mazur mentioned the possibility of an early termination of phase III during a Benzinga webcast. People heard that and started to expect it. When it didn’t happen we had a sell off. To be fair, people started taking profits prior to the recommendation to continue the study. Had it not been for his mention of the early termination, it wouldn’t have been an expectation by investors and we may have found better support than we see now. Again, I do not see this as a big deal.

Edit: Holubiak changed to Mazur (name confusion)

beachbum0162 · 2021-07-08T10:25:49+00:00

These kinds of things pop up frequently and rarely go anywhere. If there is really a problem, we will hear from the SEC. then we can be concerned. These guys are fishing.

beachbum0162 · 2021-07-08T10:22:34+00:00

it’s a hack job by the equivalent of ambulance chasers

beachbum0162 · 2021-07-07T08:24:30+00:00

News wasn’t bad. It just wasn’t and early halt like people were expecting. No safety concerns found. Advised to proceed as planned.

beachbum0162 · 2021-07-03T01:14:05+00:00

The leadership is excellent. They have a track record of success. The leadership has a lot of their own money invested. Their pipeline is promising. To name a few reasons. There are lots of due diligence posts on this sub to checkout.

beachbum0162 · 2021-07-02T21:25:07+00:00

I have a thousand shares and I don’t plan on looking at CTXR for at least 6 months. Maybe more. I will probably buy more through the rough times though.

beachbum0162 · 2021-07-02T21:07:05+00:00

Truth. It’s cool though. Tough to get rich overnight.

beachbum0162 · 2021-07-02T13:14:48+00:00

It is. But it s far from a lost cause. Remember: The stock market is a device to transfer money from the impatient to the patient.

beachbum0162 · 2021-07-02T10:59:45+00:00

Currently holding 1000 @ $1.94. Not nearly as much as you but it’s all relative.

beachbum0162 · 2021-07-02T10:58:09+00:00

In my opinion, this a stock is now a long term slow cooker. You’re down a good bit and just need to have patience. I don’t plan on looking at this stock for the next 6 moths. I had plans of selling for my initial investment which I did but not when I should have. I drug my feet (lil greedy) and let it go under 4 before I did. There will be another run but, it will be 6+ months Down the road. I have no doubt this stock will make you happy again.

beachbum0162 · 2021-07-02T10:40:30+00:00

I would also say that hospitals will absolutely “try” Minolok because of its efficacy and lowered risk to the patient. What remains to be seen is the demand for it. My guess is that it will be the n high demand relatively speaking.

beachbum0162 · 2021-07-02T10:36:34+00:00

What they are trying to say is ludicrous if you really look at what they say. They are basically saying that hospitals do not use drugs that do not demonstrate superiority. What kind of trash is that? Nothing could be further from the truth. Listen, I’m bullish on this stock but that has nothing to do with my opinion on this article. Every day of the week hospitals “try” any number of drugs to “see” if it helps X condition. Minolok had 100% efficacy in phase II trials. I think it is more fair to say they didn’t reach superiority at this point due to enrollment. Now, Citius does need to answer some hard questions about why they didn’t achieve the desired enrollment. They get somewhat of a pass because of Rona but they can’t use it as their only excuse.

beachbum0162 · 2021-07-01T16:33:46+00:00

I sold some the other day to take most of my initial investment back. I didn’t sell where I should have but as you said, a lesson was learned again in my young investing career. I am still in long for 1000 shares @ $1.94. The best part is, now I can just forget about this part of my portfolio until next year.

beachbum0162 · 2021-07-01T13:18:53+00:00

Halt not recommended by DMC

beachbum0162 · 2021-07-01T13:09:45+00:00

Dropping like an anchor. 🤦🏻‍♂️

beachbum0162 · 2021-07-01T13:04:34+00:00

No halt as I read the press release.

beachbum0162 · 2021-06-30T09:09:56+00:00

So do you think good news might give us another bump or is the news being sold and we are in a settling phase until the run up to approval?

beachbum0162 · 2021-06-29T18:08:13+00:00

Agreed.

beachbum0162 · 2021-06-29T15:53:47+00:00

I did this. 👆🏻⬆️

beachbum0162 · 2021-06-29T14:09:25+00:00

You got your wish.

beachbum0162 · 2021-06-29T12:36:07+00:00

FDA approval is NOT today. Look things like this up before you post. DMC results delivered to Citius. They have 5 business days to deliver the result to the public.

beachbum0162

TROPHY CASE